279 related articles for article (PubMed ID: 19361515)
21. Heat shock protein 90 modulates the unfolded protein response by stabilizing IRE1alpha.
Marcu MG; Doyle M; Bertolotti A; Ron D; Hendershot L; Neckers L
Mol Cell Biol; 2002 Dec; 22(24):8506-13. PubMed ID: 12446770
[TBL] [Abstract][Full Text] [Related]
22. Structure of unliganded GRP94, the endoplasmic reticulum Hsp90. Basis for nucleotide-induced conformational change.
Dollins DE; Immormino RM; Gewirth DT
J Biol Chem; 2005 Aug; 280(34):30438-47. PubMed ID: 15951571
[TBL] [Abstract][Full Text] [Related]
23. Natural Product Inspired N-Terminal Hsp90 Inhibitors: From Bench to Bedside?
Khandelwal A; Crowley VM; Blagg BSJ
Med Res Rev; 2016 Jan; 36(1):92-118. PubMed ID: 26010985
[TBL] [Abstract][Full Text] [Related]
24. 5'-N-ethylcarboxamidoadenosine is not a paralog-specific Hsp90 inhibitor.
Liu S; Street TO
Protein Sci; 2016 Dec; 25(12):2209-2215. PubMed ID: 27667530
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis, and evaluation of a radicicol and geldanamycin chimera, radamide.
Clevenger RC; Blagg BS
Org Lett; 2004 Nov; 6(24):4459-62. PubMed ID: 15548050
[TBL] [Abstract][Full Text] [Related]
26. Antibiotic radicicol binds to the N-terminal domain of Hsp90 and shares important biologic activities with geldanamycin.
Schulte TW; Akinaga S; Soga S; Sullivan W; Stensgard B; Toft D; Neckers LM
Cell Stress Chaperones; 1998 Jun; 3(2):100-8. PubMed ID: 9672245
[TBL] [Abstract][Full Text] [Related]
27. Grp94, the endoplasmic reticulum Hsp90, has a similar solution conformation to cytosolic Hsp90 in the absence of nucleotide.
Krukenberg KA; Böttcher UM; Southworth DR; Agard DA
Protein Sci; 2009 Sep; 18(9):1815-27. PubMed ID: 19554567
[TBL] [Abstract][Full Text] [Related]
28. Geldanamycin, radicicol, and chimeric inhibitors of the Hsp90 N-terminal ATP binding site.
Hadden MK; Lubbers DJ; Blagg BS
Curr Top Med Chem; 2006; 6(11):1173-82. PubMed ID: 16842154
[TBL] [Abstract][Full Text] [Related]
29. Adenosine nucleotides and the regulation of GRP94-client protein interactions.
Rosser MF; Trotta BM; Marshall MR; Berwin B; Nicchitta CV
Biochemistry; 2004 Jul; 43(27):8835-45. PubMed ID: 15236592
[TBL] [Abstract][Full Text] [Related]
30. First Structural View of a Peptide Interacting with the Nucleotide Binding Domain of Heat Shock Protein 90.
Raman S; Singh M; Tatu U; Suguna K
Sci Rep; 2015 Nov; 5():17015. PubMed ID: 26599366
[TBL] [Abstract][Full Text] [Related]
31. Structural transitions accompanying the activation of peptide binding to the endoplasmic reticulum Hsp90 chaperone GRP94.
Wearsch PA; Voglino L; Nicchitta CV
Biochemistry; 1998 Apr; 37(16):5709-19. PubMed ID: 9548957
[TBL] [Abstract][Full Text] [Related]
32. Posttranslational modification and conformational state of heat shock protein 90 differentially affect binding of chemically diverse small molecule inhibitors.
Beebe K; Mollapour M; Scroggins B; Prodromou C; Xu W; Tokita M; Taldone T; Pullen L; Zierer BK; Lee MJ; Trepel J; Buchner J; Bolon D; Chiosis G; Neckers L
Oncotarget; 2013 Jul; 4(7):1065-74. PubMed ID: 23867252
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis, and biological evaluation of hydroquinone derivatives of 17-amino-17-demethoxygeldanamycin as potent, water-soluble inhibitors of Hsp90.
Ge J; Normant E; Porter JR; Ali JA; Dembski MS; Gao Y; Georges AT; Grenier L; Pak RH; Patterson J; Sydor JR; Tibbitts TT; Tong JK; Adams J; Palombella VJ
J Med Chem; 2006 Jul; 49(15):4606-15. PubMed ID: 16854066
[TBL] [Abstract][Full Text] [Related]
34. Development of a Grp94 inhibitor.
Duerfeldt AS; Peterson LB; Maynard JC; Ng CL; Eletto D; Ostrovsky O; Shinogle HE; Moore DS; Argon Y; Nicchitta CV; Blagg BS
J Am Chem Soc; 2012 Jun; 134(23):9796-804. PubMed ID: 22642269
[TBL] [Abstract][Full Text] [Related]
35. Client Proteins and Small Molecule Inhibitors Display Distinct Binding Preferences for Constitutive and Stress-Induced HSP90 Isoforms and Their Conformationally Restricted Mutants.
Prince TL; Kijima T; Tatokoro M; Lee S; Tsutsumi S; Yim K; Rivas C; Alarcon S; Schwartz H; Khamit-Kush K; Scroggins BT; Beebe K; Trepel JB; Neckers L
PLoS One; 2015; 10(10):e0141786. PubMed ID: 26517842
[TBL] [Abstract][Full Text] [Related]
36. Structure of the ATP-binding domain of Plasmodium falciparum Hsp90.
Corbett KD; Berger JM
Proteins; 2010 Oct; 78(13):2738-44. PubMed ID: 20635416
[TBL] [Abstract][Full Text] [Related]
37. The Hsp90 inhibitor radicicol interacts with the ATP-binding pocket of bacterial sensor kinase PhoQ.
Guarnieri MT; Zhang L; Shen J; Zhao R
J Mol Biol; 2008 May; 379(1):82-93. PubMed ID: 18440021
[TBL] [Abstract][Full Text] [Related]
38. NMR chemical shift perturbation study of the N-terminal domain of Hsp90 upon binding of ADP, AMP-PNP, geldanamycin, and radicicol.
Dehner A; Furrer J; Richter K; Schuster I; Buchner J; Kessler H
Chembiochem; 2003 Sep; 4(9):870-7. PubMed ID: 12964162
[TBL] [Abstract][Full Text] [Related]
39. Transformation of the Non-Selective Aminocyclohexanol-Based Hsp90 Inhibitor into a Grp94-Seletive Scaffold.
Mishra SJ; Ghosh S; Stothert AR; Dickey CA; Blagg BS
ACS Chem Biol; 2017 Jan; 12(1):244-253. PubMed ID: 27959508
[TBL] [Abstract][Full Text] [Related]
40. Radicicol-sensitive peptide binding to the N-terminal portion of GRP94.
Vogen S; Gidalevitz T; Biswas C; Simen BB; Stein E; Gulmen F; Argon Y
J Biol Chem; 2002 Oct; 277(43):40742-50. PubMed ID: 12189140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
